Advertisement Sosei gets Japan MHLW approval for NorLevo emergency contraceptive pill - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sosei gets Japan MHLW approval for NorLevo emergency contraceptive pill

Sosei has received the Japan Ministry of Health, Labour and Welfare (MHLW) approval for its emergency contraceptive pill, NorLevo tablets 0.75mg.

NorLevo is an oral emergency contraceptive, which is taken within 72 hours after unprotected sexual intercourse or contraceptive failure to prevent unwanted pregnancy.

Sosei has taken over the exclusive distribution rights to the product in Japan and Australia from Laboratoire HRA Pharma in April 2001.

ASKA Pharmaceutical has the commercialization rights for NorLevo in Japan, under an agreement signed between Sosei and ASKA Pharmaceutical.

Further, the company is planning to launch the product in the middle of May 2011.